$155.47
+1.65%
N/A+$2.52
의료
생명공학
NASDAQ
활발히 거래 중
Palvella Therapeutics, Inc.는 중증이고 흔치 않은 유전성 피부 질환으로 고통받는 환자들을 위한 혁신적 치료제의 발견, 개발, 상용화를 목적으로 하는 임상 단계 바이오제약 ...
Palvella Therapeutics, Inc.는 중증이고 흔치 않은 유전성 피부 질환으로 고통받는 환자들을 위한 혁신적 치료제의 발견, 개발, 상용화를 목적으로 하는 임상 단계 바이오제약 ...
| 날짜 | 임원 | 직책 | 증권 | 구분 | 주식 수 | 가격 |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Goin Kathleen | officer: Chief Operating Officer | Stock Option (Right to Buy) | D | 2,154 | $7.14 |
| Aug 19, 2026 | Goin Kathleen | officer: Chief Operating Officer | Common Stock | A | 2,148 | $9.08 |
| Aug 19, 2026 | Goin Kathleen | officer: Chief Operating Officer | Stock Option (Right to Buy) | D | 2,148 | $9.08 |
| Aug 19, 2026 | Goin Kathleen | officer: Chief Operating Officer | Common Stock | D | 1,500 | $151.39 |
| Aug 19, 2026 | Goin Kathleen | officer: Chief Operating Officer | Common Stock | A | 2,154 | $7.14 |
매수/매도 주식 수와 종가 추세(공통 일간 가격 소스)
X축: 주식 수, 총 주식 수 내림차순
X축: 건수, A+D 건수 내림차순
| 날짜 | 임원 | 직책 | 증권 | 구분 | 주식 수 | 가격 | 금액 |
|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Goin Kathleen | officer: Chief Operating Officer | Stock Option (Right to Buy) | D | 2,154 | $7.14 | $15,379.56 |
| Aug 19, 2026 | Goin Kathleen | officer: Chief Operating Officer | Common Stock | A | 2,148 | $9.08 | $19,503.84 |
| Aug 19, 2026 | Goin Kathleen | officer: Chief Operating Officer | Stock Option (Right to Buy) | D | 2,148 | $9.08 | $19,503.84 |
| Aug 19, 2026 | Goin Kathleen | officer: Chief Operating Officer | Common Stock | D | 1,500 | $151.39 | $227,085.00 |
| Aug 19, 2026 | Goin Kathleen | officer: Chief Operating Officer | Common Stock | A | 2,154 | $7.14 | $15,379.56 |
| Aug 19, 2026 | Goin Kathleen | officer: Chief Operating Officer | Common Stock | D | 1,998 | $151.80 | $303,292.20 |
| Aug 19, 2026 | Goin Kathleen | officer: Chief Operating Officer | Common Stock | D | 400 | $153.00 | $61,199.00 |
| Aug 19, 2026 | Goin Kathleen | officer: Chief Operating Officer | Common Stock | D | 102 | $155.59 | $15,870.16 |
| Aug 19, 2026 | Goin Kathleen | officer: Chief Operating Officer | Common Stock | D | 302 | $156.77 | $47,344.54 |
| Jul 15, 2026 | Goin Kathleen | officer: Chief Operating Officer | Stock Option (Right to Buy) | D | 2,154 | $7.14 | $15,379.56 |